MLchartDataset catalogue

PSA:154-163(155L) peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-016274

A cancer vaccine comprised of a synthetic peptide with an amino acid sequence corresponding to positions 154-163 of the amino acid sequence for prostate-specific antigen (PSA) with a leucine substitution at position 155. Upon administration, PSA:154-163(155L) peptide vaccine may elicit a cytotoxic T-cell response against tumor cells that express PSA.

Table 1. Record
IdentifierMLC-T-ONC-016274
FieldOncology and biomedicine
AbbreviationPSA PEP VAC
SynonymsPSA-3A
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016274",
  "term": "PSA:154-163(155L) peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine comprised of a synthetic peptide with an amino acid sequence corresponding to positions 154-163 of the amino acid sequence for prostate-specific antigen (PSA) with a leucine substitution at position 155. Upon administration, PSA:154-163(155L) peptide vaccine may elicit a cytotoxic T-cell response against tumor cells that express PSA.",
  "abbreviation": "PSA PEP VAC",
  "synonyms": [
    "PSA-3A"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/psa-154-163-155l-peptide-vaccine/"
}

Record 13,803 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.